PM2.5 exposure exacerbates airway pyroptosis related inflammatory response in asthmatic mice by activating NLRP3 inflammasome
- Toxicology. 2025 Dec 18:521:154376. doi: 10.1016/j.tox.2025.154376.
- 1. Department of Pediatrics, Zhongnan Hospital of Wuhan University, Wuhan, China; Department of Respiratory Medicine, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: [email protected].
- 2. Department of Pediatrics, Zhongnan Hospital of Wuhan University, Wuhan, China. Electronic address: [email protected].
- 3. Department of Pediatrics, Zhongnan Hospital of Wuhan University, Wuhan, China; Department of Pediatrics, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China. Electronic address: [email protected].
- 4. Department of Pediatrics, Zhongnan Hospital of Wuhan University, Wuhan, China. Electronic address: [email protected].
- 5. Department of Pediatrics, Zhongnan Hospital of Wuhan University, Wuhan, China. Electronic address: [email protected].
- 6. Department of Pediatrics, Zhongnan Hospital of Wuhan University, Wuhan, China. Electronic address: [email protected].
- 7. Department of Pediatrics, Zhongnan Hospital of Wuhan University, Wuhan, China; Children's digital health and data Center of Wuhan University, Wuhan, Hubei, China. Electronic address: [email protected].
Background: Fine particulate matter (PM2.5)-induced airway epithelial damage plays a pivotal role in driving the development of airway inflammation. Although Pyroptosis is recognized for its highly proinflammatory nature, its precise role in PM2.5-associated airway inflammation, particularly in asthmatic condition, remains to be fully elucidated.
Methods: In ovalbumin (OVA)-sensitized asthmatic mice, we assessed pulmonary histopathology, inflammatory cell counts and Th2 cytokine levels (IL-4, IL-5, and IL-13) in bronchoalveolar lavage fluid (BALF), airway hyperresponsiveness (AHR), and airway epithelial Pyroptosis. To investigate the effects of PM2.5 on airway epithelial cells, BEAS-2B cells were exposed to PM2.5. Cell viability was evaluated using the CCK-8 assay, while pyroptosis-related protein levels and inflammatory cytokine release were analyzed by Western blot and ELISA, respectively. Additionally, transmission electron microscopy (TEM) was employed to examine PM2.5-induced ultrastructural changes in BEAS-2B cells. To further elucidate the underlying mechanism, we administered the NLRP3 Inhibitor MCC950 and the Caspase-1 inhibitor Ac-YVAD-cmk to verify the involvement of NLRP3 inflammasome activation and Pyroptosis in PM2.5-exposed asthmatic mice.
Results: PM2.5 exposure significantly aggravated airway inflammation in asthmatic mice, as demonstrated by elevated histopathological inflammatory scores in lung tissues and increased pro-inflammatory cytokine levels in BALF. Furthermore, PM2.5 upregulated the abundance of pyroptosis-related markers, namely NLRP3, Caspase-1, GSDMD, and IL-1β, in the lung tissues of asthmatic mice. In BEAS-2B cells, PM2.5 exposure led to a dose-dependent reduction in cell viability and promoted the activation of NLRP3 inflammasome, subsequently leading to Caspase-1-mediated GSDMD cleavage and IL-1β secretion. TEM further confirmed Pyroptosis, revealing characteristic morphological alterations such as cytoplasmic vacuolation, mitochondrial swelling, and plasma membrane pore formation in BEAS-2B cells exposed to PM2.5. Critically, inhibition of NLRP3 (MCC950) or Caspase-1 (Ac-YVAD-cmk) markedly attenuated PM2.5-induced Pyroptosis and ameliorated airway inflammation in asthmatic mice, underscoring the pivotal role of the NLRP3/Caspase-1/GSDMD axis in this pathogenic process.
Conclusion: Our findings demonstrate that PM2.5 exposure induces airway epithelial Pyroptosis through NLRP3 inflammasome activation, thereby exacerbating airway inflammation in asthmatic mice.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: NOD-like Receptor (NLR)Research Areas: Inflammation/Immunology
-
target: CaspaseResearch Areas: Inflammation/Immunology